pirenzepine has been researched along with ANS (Autonomic Nervous System) Diseases in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Olanzapine-treated patients had serum anticholinergic levels that were less than one fifth those of the clozapine-treated patients." | 2.69 | Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine. ( Brar, JS; Chengappa, KN; Kirshner, MA; Levine, J; Parepally, H; Pollock, BG; Zoretich, RA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chengappa, KN | 1 |
| Pollock, BG | 1 |
| Parepally, H | 1 |
| Levine, J | 1 |
| Kirshner, MA | 1 |
| Brar, JS | 1 |
| Zoretich, RA | 1 |
1 trial available for pirenzepine and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine.
Topics: Adult; Antipsychotic Agents; Atropine; Autonomic Nervous System Diseases; Benzodiazepines; Cholinerg | 2000 |